Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2026 15:20 ET | Source: DIAGNOS Inc.

DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists

BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of...
July 27, 2026 15:20 ET | Source: DIAGNOS inc.

Santé Canada accorde une licence d’instrument médical à DIAGNOS pour son produit CARA System, introduisant l’analyse d’images rétiniennes par IA auprès des optométristes canadiens

BROSSARD, Québec, 27 juill. 2026 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), une entreprise dédiée à la...
July 07, 2026 12:38 ET | Source: DIAGNOS Inc.

DIAGNOS to Extend the Exercise Period of Stock Warrants

BROSSARD, Quebec, July 07, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical...
June 18, 2026 12:00 ET | Source: DIAGNOS Inc.

DIAGNOS Announces Shares for Debt Settlement

BROSSARD, Quebec, June 18, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of...
June 16, 2026 09:15 ET | Source: DIAGNOS Inc.

DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform

BROSSARD, Quebec, June 16, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of...
June 16, 2026 09:15 ET | Source: DIAGNOS inc.

DIAGNOS dépose une demande de licence modifiée et mise à jour auprès de Santé Canada pour la plateforme du système CARA

BROSSARD, Québec, 16 juin 2026 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), une entreprise dédiée à la détection...
June 12, 2026 15:50 ET | Source: DIAGNOS Inc.

DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting

BROSSARD, Quebec, June 12, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of...
June 05, 2026 10:00 ET | Source: DIAGNOS Inc.

Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform

BROSSARD, Quebec, June 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of...
June 05, 2026 10:00 ET | Source: DIAGNOS inc.

Emerging Growth Research publie un rapport éclair sur DIAGNOS, mettant en lumière les catalyseurs réglementaires et le potentiel de commercialisation de la plateforme CARA AI

BROSSARD, Québec, 05 juin 2026 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), une entreprise dédiée à la détection...
June 03, 2026 10:00 ET | Source: DIAGNOS Inc.

DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026

DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. BROSSARD, Quebec, June ...